Literature DB >> 1742443

Bayesian subset analysis.

D O Dixon1, R Simon.   

Abstract

As a means of assessing the importance of variation in treatment effect among patient subsets, we derived posterior distributions for subset-specific treatment effects. The effects are represented by combinations of terms for treatment and treatment-by-covariate interaction effects in familiar regression models. Exchange-ability among the interactions is a key assumption; thus, the results are of interest primarily in the context of examining a collection of subsets with no definite a priori distinction relative to treatment effect. Exchangeability leads to a shrinking of the posterior distributions of the interaction terms toward the natural origin of 0, offsetting the tendency of the estimated effects to disperse. The method is applied to parameter estimates from a proportional hazards regression analysis of survival data from a clinical trial, invoking the approximate multivariate normal distribution of the estimates. No subjective prior distributions are required. Vague priors are used for all of the regression coefficients except the treatment-by-covariate interactions, which are assumed to follow a normal distribution.

Entities:  

Mesh:

Year:  1991        PMID: 1742443

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  29 in total

1.  Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes.

Authors:  Nan Chen; J Jack Lee
Journal:  Biom J       Date:  2018-12-03       Impact factor: 2.207

2.  Subgroup identification from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Stephen J Ruberg
Journal:  Stat Med       Date:  2011-08-04       Impact factor: 2.373

3.  On Bayesian methods of exploring qualitative interactions for targeted treatment.

Authors:  Wei Chen; Debashis Ghosh; Trivellore E Raghunathan; Maxim Norkin; Daniel J Sargent; Gerold Bepler
Journal:  Stat Med       Date:  2012-06-26       Impact factor: 2.373

4.  Costs and effectiveness of the fast track intervention for antisocial behavior.

Authors:  E Michael Foster
Journal:  J Ment Health Policy Econ       Date:  2010-09

Review 5.  Bayesian Approaches to Subgroup Analysis and Related Adaptive Clinical Trial Designs.

Authors:  Ciara Nugent; Wentian Guo; Peter Müller; Yuan Ji
Journal:  JCO Precis Oncol       Date:  2019-10-24

6.  Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment.

Authors:  Paul M Cinciripini; Charles E Green; Jason D Robinson; Maher Karam-Hage; Jeffrey M Engelmann; Jennifer A Minnix; David W Wetter; Francesco Versace
Journal:  Psychopharmacology (Berl)       Date:  2017-03-08       Impact factor: 4.530

7.  A nonparametric Bayesian basket trial design.

Authors:  Yanxun Xu; Peter Müller; Apostolia M Tsimberidou; Donald Berry
Journal:  Biom J       Date:  2018-05-28       Impact factor: 2.207

8.  Bayesian design using adult data to augment pediatric trials.

Authors:  David A Schoenfeld; Dianne M Finkelstein
Journal:  Clin Trials       Date:  2009-08       Impact factor: 2.486

9.  Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach.

Authors:  C E Green; F G Moeller; J M Schmitz; J F Lucke; S D Lane; A C Swann; R E Lasky; J P Carbonari
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

10.  Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials.

Authors:  Scott M Berry; Kristine R Broglio; Susan Groshen; Donald A Berry
Journal:  Clin Trials       Date:  2013-08-27       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.